Insulin therapy

被引:0
作者
Lechleitner, Monika [1 ,3 ]
Hoppichler, Friedrich [2 ,3 ]
机构
[1] Landeskrankenhaus Hochzirl, Zirl, Austria
[2] Krankenhaus Barmherzigen Bruder, Salzburg, Austria
[3] SIPCAN, Salzburg, Austria
关键词
Insulin therapy; preparations and regimen;
D O I
10.1007/s10354-011-0889-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin therapy is a vital hormone replacement therapy in type 1 diabetes mellitus. In type 2 diabetes, insulin is indicated if glycaemic goals are not reached by oral antidiabetics, as well as for metabolic detoriation, co-morbidities, surgery, pregnancy or contradictions against oral antidiabetics. Insulin preparations are characterized by the onset of the insulin action, the peak profile and duration of action. Available are short acting, long-acting and premixed preparations of human insulin, and insulin analogues. The gold standard of insulin therapy in type 1 diabetes is functional insulin therapy with a basal-bolus insulin regimen and control and adaption of the therapy by the patient. Various insulin regimens are available for treating patients with type 2 diabetes, including basal insulin supported oral therapy, supplementary mealtime injection of short acting insulin or insulin analogues, conventional insulin therapy or a basal bolus procedure. The various insulin preparations and regimens make it possible to adapt the therapy according to the patient. s individual need.
引用
收藏
页码:300 / 304
页数:5
相关论文
共 34 条
[1]  
American Diabetes Association, 2010, DIABETES CARE S1, V34, pS4
[2]  
Barlocco Daniela, 2003, Curr Opin Investig Drugs, V4, P1240
[3]   Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials [J].
Bazzano, L. A. ;
Lee, L. J. ;
Shi, L. ;
Reynolds, K. ;
Jackson, J. A. ;
Fonseca, V. .
DIABETIC MEDICINE, 2008, 25 (08) :924-932
[4]   Insulin Pump Use in Type 2 Diabetes [J].
Bode, Bruce W. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 :S17-S21
[5]   Initiating insulin therapy in type 2 diabetes: Benefits of insulin analogs and insulin pens [J].
Brunton, Stephen .
DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (04) :247-256
[6]   Insulin aspart - A review of its use in the management of type 1 and 2 diabetes mellitus [J].
Chapman, TM ;
Noble, S ;
Goa, KL .
DRUGS, 2002, 62 (13) :1945-1981
[7]  
Clodi M, 2009, WIEN KLIN WOCHENS S5, V121, P13
[8]   Premixed insulin analogues for the treatment of diabetes mellitus [J].
Garber, AJ .
DRUGS, 2006, 66 (01) :31-49
[9]   Differences between long-acting insulins for the treatment of type 2 diabetes [J].
Gejl, Michael ;
Hansen, Mikkel ;
Brock, Birgitte ;
Rungby, Jorgen .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (12) :2027-2035
[10]   Insulin glargine: long-acting basal insulin analog for improved metabolic control [J].
Gerich, JE .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (01) :31-37